Molecular aspects of arrhythmias associated with cardiomyopathies.
about
Mechanisms of action of antiarrhythmic drugs relative to the origin and perpetuation of cardiac arrhythmias.NF-kappaB-dependent transcriptional regulation of the cardiac scn5a sodium channel by angiotensin II.Cardiac-restricted angiotensin-converting enzyme overexpression causes conduction defects and connexin dysregulation.Antiarrhythmic action of beta-blockers: potential mechanisms.Cardionomics: a new integrative approach for screening cardiotoxicity of drug candidates.Transient-outward K+ channel inhibition facilitates L-type Ca2+ current in heart.
P2860
Molecular aspects of arrhythmias associated with cardiomyopathies.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Molecular aspects of arrhythmias associated with cardiomyopathies.
@ast
Molecular aspects of arrhythmias associated with cardiomyopathies.
@en
Molecular aspects of arrhythmias associated with cardiomyopathies.
@nl
type
label
Molecular aspects of arrhythmias associated with cardiomyopathies.
@ast
Molecular aspects of arrhythmias associated with cardiomyopathies.
@en
Molecular aspects of arrhythmias associated with cardiomyopathies.
@nl
prefLabel
Molecular aspects of arrhythmias associated with cardiomyopathies.
@ast
Molecular aspects of arrhythmias associated with cardiomyopathies.
@en
Molecular aspects of arrhythmias associated with cardiomyopathies.
@nl
P1476
Molecular aspects of arrhythmias associated with cardiomyopathies.
@en
P2093
P304
P356
10.1097/00001573-200005000-00014
P577
2000-05-01T00:00:00Z